Measure neuroprotection and impact on cell health in a complex organoid (astrocytes and multiple neuronal subtypes).
Next-Generation lead compound identification and optimisation with
A ground-breaking solution for cell preservation
Tools for growth, harvesting & storage. AMSBIO is a leading provider of quality life science research reagents and services.
Get robust compound data in human tissue models through our OrganoServices. With proven phenotypic assays in the OrganoPlate® platform, we support your drug discovery and development needs.
Organoids for Oncology Drug Development Preclinical oncology drug development and validation services using tumor organoids and the HUB tumor organoid biobank.
Compound Profiling & Screening Services. Custom Model & Assay Development. Drug Development Partnerships
Drug discovery has to change — and we reimagine the path from target to hit, lead, and candidate by leveraging the power of Ulysses®, our unique, integrated drug discovery platform.
Experience gained through multiple research projects has enabled Cellesce to develop its IP and introduce a range of organoid products and services
Providing general consultation for your research project, developing specific screening assays.
3D Screening of spheroids
Preclinical in Vitro screening of liver organoids Epistem Research Services
3D Tumor Cell Culture Models
End-to-end partners in your drug discovery journey including iPSC services and iPSC-derived intestinal organoids provide a unique in vitro system to model the human intestine.
Epistem provide in vitro intestinal and liver organoid assay services under a license agreement with the HUB.
Organoid-specialized drug development innovation company in Korea to develop treatments for incurable disease
The Incucyte® Organoid Assay uses an established protocol and purpose-built software, for continuous acquisition and objective analysis of organoid size, count and morphology in a microplate format all from inside your incubator.